What does the prescribing information recommend about breastfeeding during ceritinib treatment?

For ceritinib (Zykadia), decide whether to discontinue breastfeeding or discontinue/abstain from therapy, considering breastfeeding benefits for the child and treatment benefits for the woman, because milk excretion of ceritinib/metabolites is unknown and infant risk cannot be excluded.